Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05762445 · ClinicalTrials.gov registry record
PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)
A clinical trial, sponsored by CorEvitas.
- Completed
- Registry status
- 400
- Enrollment target
NCT05762445 is a clinical trial that has completed, run by CorEvitas. The registered enrollment target is 400 participants.
The verdict
NCT05762445 has completed, sponsored by CorEvitas.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The main objective of this study is to generate real-world evidence reflecting the experience of individuals with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP). Efforts will be directed toward understanding the unmet need and therapeutic burden to identify the most critical factors that influence treatment choices/prescribing patterns, quality of life, and healthcare utilization outcomes in standard of care for individuals with EPI due to CP.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-06-02 |
| Est. Completion | 2025-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05762445
The ClinicalTrials.gov registry entry for NCT05762445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CorEvitas, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05762445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05762445 about?
NCT05762445 is a clinical study titled "PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)". The main objective of this study is to generate real-world evidence reflecting the experience of individuals with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP). Efforts will be directed toward understanding the unmet need and therapeutic burden to identify the most critica...
What is the current status of trial NCT05762445?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2021-06-02. Estimated completion is 2025-08-31.
Who is sponsoring clinical trial NCT05762445?
This trial is sponsored by CorEvitas, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.